Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Dalkon Shield contraceptive device in general practice.

J M Chadwick

    The Medical Journal of Australia
    |October 4, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The problem of antenatal diagnosis of microcephaly by ultrasonography in twin pregnancy.

    The Australian & New Zealand journal of obstetrics & gynaecology·1983
    Same author

    Ultrastructural and cell surface changes of human psoriatic skin following Goeckerman therapy.

    Journal of cutaneous pathology·1979
    Same author

    Auricular calcification.

    International journal of dermatology·1978
    Same author

    Topical sulfadiazine silver for bullous pemphigoid.

    Archives of dermatology·1978
    Same author

    Letter: Gravigard (copper 7) IUCD.

    The Medical journal of Australia·1976
    Same author

    A possible case of analgesic abuse associated with transitional-cell carcinoma of the bladder.

    The Medical journal of Australia·1970

    The Dalkon Shield showed a disappointingly low continuation rate for birth control among motivated women. This contradicts previous research, highlighting potential issues with this contraceptive method.

    Area of Science:

    • Reproductive Health
    • Contraception
    • Public Health

    Background:

    • The Dalkon Shield was a widely used intrauterine device (IUD) for contraception.
    • Previous studies suggested high continuation rates for the Dalkon Shield.
    • Assessing the real-world effectiveness and patient acceptance in general practice is crucial.

    Purpose of the Study:

    • To evaluate the continuation rate of the Dalkon Shield in a general practice setting.
    • To compare findings with previous research on the Dalkon Shield's performance.
    • To identify potential factors influencing patient adherence to the Dalkon Shield.

    Main Methods:

    • Review of patient data and continuation rates for the Dalkon Shield.
    • Analysis of a cohort of well-motivated women using the Dalkon Shield for birth control.

    Related Experiment Videos

  • Comparison of observed continuation rates with historical data.

    • Main Results:

    • The Dalkon Shield exhibited a disappointingly low continuation rate.
    • This low rate was observed even in a group of women highly motivated to use contraception.
    • Findings contrast sharply with previously published positive results (Watson, 1975).

    Conclusions:

    • The Dalkon Shield's performance in general practice may be suboptimal.
    • Patient motivation alone did not ensure high continuation rates for this device.
    • Further investigation into the Dalkon Shield's limitations and patient experience is warranted.